AsaPharma Wound Hemostatic Powder
Asapharma’s hemostatic products significantly reduce the time it takes to stop bleeding in all types of trauma, surgical incisions, angiography catheters, dialysis patients, and vascular insufficiency.
This product has also found increasing use in the field of hereditary bleeding diseases. Including in surgery, dentistry, nosebleeds, mouth and teeth, circumcision, and traumatic wounds in hemophiliac patients. Asapharma’s hemostatic products are free of any sensitivity, skin irritation, cellular toxicity, acute and semi-chronic toxicity, and genetic toxicity, and their effectiveness has been proven in clinical studies in accordance with international standards.
Asapharma’s hemostatic product has played a very important role in improving medical services by quickly stopping all types of arterial, venous, and capillary bleeding in the shortest possible time, saving patients’ lives, reducing hospital costs, reducing hospitalization time, converting the type of treatment from inpatient to outpatient, reducing the need for blood transfusions, and reducing the transmission of infections.
One of the main causes of mortality in accidents and wars is excessive bleeding of patients and soldiers. Therefore, using a product that controls the bleeding process of wounds and increases the speed of blood clotting plays a major role in reducing the death rate from accidents and also strengthening the army’s forces. In addition, common methods of accelerating blood clotting are not effective in patients with blood clotting problems or patients taking anticoagulant drugs such as warfarin and clopidogrel.
Asapharma’s hemostatic product is a powdered dressing that is very effective in accelerating the blood hemostasis process, increasing the speed of blood clotting and preventing bleeding in patients who have suffered accidents.
Mechanism of action
Absorption of blood plasma and concentration of hemostatic factors such as prothrombin
Local increase in platelet and red blood cell population and acceleration of platelet nail formation
This powder prevents postoperative adhesion and dissolves in the body within 7 to 24 hours and stops bleeding in 40-90 seconds.
Features of Asapharma's hemostatic agent
- Fast and easy operation
- Independent of blood coagulation pathways
- No heat generation at the bleeding site
- Biocompatible and free of genotoxicity, cellular and systemic
- No sensitivity and irritation
How to use
- Clean the wound from blood
- Apply an appropriate amount of Asapharma Hemostatic Powder directly onto the bleeding site
- Place a sterile gauze pad over the bleeding site and press firmly for 1 to 3 minutes
Applications
All cardiovascular, ENT, graft, orthopedic and laparoscopic surgeries
Soft tissue surgeries
Angiography site hemostasis
Suitable for stopping bleeding in people with diabetes
Suitable for all patients with coagulation problems
Stopping capillary, venous and arterial bleeding
Contraindications
Asapharma Hemostatic Agent should not be injected into a vein.
When Asapharma Hemostatic Agent is used to stop bleeding in bone tissue, spine, and neurosurgery, it should be removed from the site after the bleeding has stopped, as the swelling of the powder can cause slight pressure.
Asapharma Hemostatic Agent should not be used for bone implant cases such as fractures, as there is a possibility of interference with bone cell production and an increased risk of cyst formation.
Warnings
Although Asapharma Hemostatic has antibacterial properties, systematic preventive measures should be taken to prevent postoperative infections.